Pharmaceutical Company-B (01672.HK) spent 0.477 million Hong Kong dollars to repurchase 0.3 million shares on November 13th.

GLEEN Pharmaceutical-B (01672.HK) announced on November 13th that it spent 0.477 million Hong Kong dollars to repurchase 0.3 million shares.

Gelonghui FinanceNov 13 05:09 ET

Express News | Ascletis Pharma Inc - Topline Results Expected in Q2 2025

ReutersNov 12 06:30 ET

Express News | Ascletis Completes Enrollment of Phase III Trial of Asc40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

ReutersNov 12 06:30 ET

Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

PR NewswireNov 12 06:30 ET

Ascletis Pharma Gets Favorable Phase I Clinical Trial Results for Cholesterol Drug

MT NewswiresNov 8 00:10 ET

Express News | Ascletis Announces Promising Results From a Phase I Study in Australia for First-in-Class Muscle-Preserving Weight Loss Drug Candidate Asc47 for the Treatment of Obesity

ReutersNov 7 06:30 ET